{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:02:11Z","timestamp":1792026131487,"version":"4.4.0"},"reference-count":33,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Ovarian cancer surgery requires multiple radical resections with a high risk of complications. The aim of this single-centre, retrospective study was to determine the best method for predicting Clavien\u2013Dindo grade \u2265 III complications using machine learning techniques. Material and Methods: The study included 179 patients who underwent surgery at the gynaecological oncology department of Antalya Training and Research Hospital between January 2015 and December 2020. The data were randomly split into training set n = 134 (75%) and test set n = 45 (25%). We used 49 predictors to develop the best algorithm. Mean absolute error, root mean squared error, correlation coefficients, Mathew\u2019s correlation coefficient, and F1 score were used to determine the best performing algorithm. Cohens\u2019 kappa value was evaluated to analyse the consistency of the model with real data. The relationship between these predicted values and the actual values were then summarised using a confusion matrix. True positive (TP) rate, False positive (FP) rate, precision, recall, and Area under the curve (AUC) values were evaluated to demonstrate clinical usability and classification skills. Results: 139 patients (77.65%) had no morbidity or grade I-II CDC morbidity, while 40 patients (22.35%) had grade III or higher CDC morbidity. BayesNet was found to be the most effective prediction model. No dominant parameter was observed in the Bayesian net importance matrix plot. The true positive (TP) rate was 76%, false positive (FP) rate was 15.6%, recall rate (sensitivity) was 76.9%, and overall accuracy was 82.2% A receiver operating characteristic (ROC) analysis was performed to estimate CDC grade \u2265 III. AUC was 0.863 with a statistical significance of p &lt; 0.001, indicating a high degree of accuracy. Conclusions: The Bayesian network model achieved the highest accuracy compared to all other models in predicting CDC Grade \u2265 III complications following epithelial ovarian cancer surgery.<\/jats:p>","DOI":"10.3390\/medicina61040695","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:46:20Z","timestamp":1744274780000},"page":"695","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prediction of Clavien Dindo Classification \u2265 Grade III Complications After Epithelial Ovarian Cancer Surgery Using Machine Learning Methods"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7912-7375","authenticated-orcid":false,"given":"Aysun","family":"Alci","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology, Health Sciences University Antalya Training and Research Hospital, Antalya 07100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3710-2193","authenticated-orcid":false,"given":"Fatih","family":"Ikiz","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Health Sciences University Beyhekim Training and Research Hospital, Konya 42060, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5980-3244","authenticated-orcid":false,"given":"Necim","family":"Yalcin","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Health Sciences University Antalya Training and Research Hospital, Antalya 07100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0477-157X","authenticated-orcid":false,"given":"Mustafa","family":"Gokkaya","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Health Sciences University Antalya Training and Research Hospital, Antalya 07100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-7603","authenticated-orcid":false,"given":"Gulsum Ekin","family":"Sari","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Health Sciences University Antalya Training and Research Hospital, Antalya 07100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3491-4682","authenticated-orcid":false,"given":"Isin","family":"Ureyen","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Health Sciences University Antalya Training and Research Hospital, Antalya 07100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6706-6915","authenticated-orcid":false,"given":"Tayfun","family":"Toptas","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Health Sciences University Antalya Training and Research Hospital, Antalya 07100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"ref_1","unstructured":"PDQ Adult Treatment Editorial Board (2024). PDQ Cancer Information Summaries, Mar 14 OE, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ\u00ae): Health Professional Version."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/IGC.0b013e31826bd1f2","article-title":"Ovarian Cancer: Prevention, Detection, and Treatment of the Disease and its Recurrence. Molecular Mechanisms and Personalized Medicine Meeting Report","volume":"22","author":"Modugno","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mancari, R., Cutillo, G., Bruno, V., Vincenzoni, C., Mancini, E., Baiocco, E., Bruni, S., Vocaturo, G., Chiofalo, B., and Vizza, E. (2020). Development of new medical treatment for epithelial ovarian cancer recurrence. Gland Surg., 9.","DOI":"10.21037\/gs-20-413"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: A prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zou, R., Jiang, Q., Luo, X., Chen, M., Yuan, L., and Yao, L. (2023). Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer. World J. Surg. Oncol., 21.","DOI":"10.1186\/s12957-023-03230-3"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2016.11.022","article-title":"Chemotherapy delay after primary debulking surgery for ovarian cancer","volume":"144","author":"Seagle","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kengsakul, M., Nieuwenhuyzen-de Boer, G.M., Udomkarnjananun, S., Kerr, S.J., van Doorn, H.C., and van Beekhuizen, H.J. (2022). Factors Predicting 30-Day Grade IIIa\u2013V Clavien\u2013Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: A Prospective Cohort Study. Cancers, 14.","DOI":"10.3390\/cancers14174181"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2020.11.021","article-title":"Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events","volume":"160","author":"Straubhar","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/bjs.1800780327","article-title":"POSSUM: A scoring system for surgical audit","volume":"78","author":"Copeland","year":"1991","journal-title":"Br. J. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jamcollsurg.2006.11.011","article-title":"An Apgar score for surgery","volume":"204","author":"Gawande","year":"2007","journal-title":"J. Am. Coll. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jamcollsurg.2013.07.385","article-title":"Development and evaluation of the universal ACS NSQIP surgical risk calculator: A decision aid and informed consent tool for patients and surgeons","volume":"217","author":"Bilimoria","year":"2013","journal-title":"J. Am. Coll. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cruz, J.A., and Wishart, D.S. (2006). Applications of machine learning in cancer prediction and prognosis. Cancer Inform., 2.","DOI":"10.1177\/117693510600200030"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Miller, R.A., Pople, H.E., and Myers, J.D. (1985). Internist-I, an experimental computer-based diagnostic consultant for general internal medicine. Computer-Assisted Medical Decision Making, Springer.","DOI":"10.1007\/978-1-4612-5108-8_8"},{"key":"ref_16","unstructured":"Turing, A.M. (2009). Computing Machinery and Intelligence, Springer."},{"key":"ref_17","unstructured":"Alpaydin, E. (2020). Introduction to Machine Learning, MIT Press."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Liang, Z., Zhang, G., Huang, J.X., and Hu, Q.V. (2014, January 2\u20135). Deep learning for healthcare decision making with EMRs. Proceedings of the 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), Belfast, UK.","DOI":"10.1109\/BIBM.2014.6999219"},{"key":"ref_19","unstructured":"Silver, D.L. (2011, January 3\u20136). Machine lifelong learning: Challenges and benefits for artificial general intelligence. Proceedings of the Artificial General Intelligence: 4th International Conference, AGI 2011, Mountain View, CA, USA."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.ejca.2013.06.013","article-title":"Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial","volume":"49","author":"Tajik","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2015.10.025","article-title":"Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer","volume":"140","author":"Kumar","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2015.03.043","article-title":"Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery","volume":"137","author":"Panici","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00404-021-06116-5","article-title":"ECOG and BMI as preoperative risk factors for severe postoperative complications in ovarian cancer patients: Results of a prospective study (RISC-GYN\u2014Trial)","volume":"304","author":"Inci","year":"2021","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"571.e1","DOI":"10.1016\/j.ajog.2019.02.019","article-title":"Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer","volume":"220","author":"Cham","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.sopen.2019.05.005","article-title":"Aggressive surgery for advanced ovarian cancer performed by a multidisciplinary team: A retrospective analysis on a large series of patients","volume":"1","author":"Rausei","year":"2019","journal-title":"Surg. Open Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5603\/GP.2019.0097","article-title":"The parameters to estimate postoperative severe complications classified through Clavien-Dindo after upper abdominal surgery in patients with primary and recurrent ovarian cancer","volume":"90","author":"Yalcin","year":"2019","journal-title":"Ginekol. Pol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hernandez, M.C., Chen, C., Nguyen, A., Choong, K., Carlin, C., Nelson, R.A., Rossi, L.A., Seth, N., McNeese, K., and Yuh, B. (2024). Explainable Machine Learning Model to Preoperatively Predict Postoperative Complications in Inpatients With Cancer Undergoing Major Operations. JCO Clin. Cancer Inform., 8.","DOI":"10.1200\/CCI.23.00247"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Deng, H., Eftekhari, Z., Carlin, C., Veerapong, J., Fournier, K.F., Johnston, F.M., Dineen, S.P., Powers, B.D., Hendrix, R., and Lambert, L.A. (2022). Development and validation of an explainable machine learning model for major complications after cytoreductive surgery. JAMA Netw. Open, 5.","DOI":"10.1001\/jamanetworkopen.2022.12930"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yang, Z., Zhang, Y., Zhuo, L., Sun, K., Meng, F., Zhou, M., and Sun, J. (2024). Prediction of prognosis and treatment response in ovarian cancer patients from histopathology images using graph deep learning: A multicenter retrospective study. Eur. J. Cancer., 199.","DOI":"10.1016\/j.ejca.2024.113532"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jso.27896","article-title":"Delay in Time to Adjuvant Chemotherapy and its Impact on Oncological Outcomes in Patients Undergoing Optimal Cytoreductive Surgery for Advanced Ovarian Cancer: Analysis of 1480 Cases From the Indian HIPEC Registry","volume":"130","author":"Sp","year":"2024","journal-title":"J. Surg. Oncol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/695\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:12:15Z","timestamp":1760029935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["medicina61040695"],"URL":"https:\/\/doi.org\/10.3390\/medicina61040695","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}